CAS: 1382979-44-3
![2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]-](https://static.cymitquimica.com/products/IN/thumb/DA0018GR.jpg)
2-Pyrimidinamine, 5-[8,9-dihydro-6,6-dimethyl-4-(4-morpholinyl)-6H-[1,4]oxazino[4,3-e]purin-2-yl]-
CAS:1382979-44-3
Formula:
C18H22N8O2
Purity:
95%
Color and Shape:
Solid
Molecular weight:
382.4197
Ref: IN-DA0018GR
| 5mg | 50.00 € | ||
| 10mg | 65.00 € | ||
| 25mg | 103.00 € | ||
| 50mg | 171.00 € | ||
| 100mg | 208.00 € | ||
| 250mg | 468.00 € |
Estimated delivery in United States, on Tuesday 7 Jan 2025
GDC0084
CAS:1382979-44-3
GDC0084 (RG7666) is a PI3K inhibitor with potential antineoplastic activity.
Formula:
C18H22N8O2
Purity:
99.16% - ≥95%
Color and Shape:
Solid
Molecular weight:
382.42
Ref: TM-T3705
| 2mg | 42.00 € | ||
| 5mg | 60.00 € | ||
| 10mg | 96.00 € | ||
| 25mg | 171.00 € | ||
| 50mg | 276.00 € | ||
| 100mg | 522.00 € |
Estimated delivery in United States, on Tuesday 14 Jan 2025
GDC 0084
CAS:1382979-44-3
PI3K and mTOR enzyme inhibitor; anti-cancer agent
Formula:
C18H22N8O2
Purity:
Min. 95%
Molecular weight:
382.42 g/mol
Ref: 3D-FD145121
| 1mg | To inquire | ||
| 2mg | To inquire | ||
| 5mg | To inquire | ||
| 10mg | To inquire | ||
| 25mg | To inquire |
Estimated delivery in United States, on Tuesday 18 Feb 2025
